ZA888089B - Tetrahydro-furo and-thieno/2,3-c/piridines - Google Patents

Tetrahydro-furo and-thieno/2,3-c/piridines

Info

Publication number: ZA888089B
Authority: ZA; South Africa
Prior art keywords: piridines; furo; thieno; tetrahydro
Prior art date: 1987-10-29

Application number

ZA888089A

Other languages

English (en)

Inventor

Albrecht Harreus

Harreus Albrecht

Karl-Heinz Weber

Weber Karl-Heinz

Gerhard Walther

Walther Gerhard

Werner Stransky

Stransky Werner

Franz Josef Kuhn

Josef Kuhn Franz

Guenther Schingnitz

Schingnitz Guenther

Helmut Ensinger

Ensinger Helmut

Original Assignee

Boehringer Ingelheim Int

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1987-10-29

Filing date

1988-10-28

Publication date

1990-07-25

1988-10-28 Application filed by Boehringer Ingelheim Int filed Critical Boehringer Ingelheim Int

1990-07-25 Publication of ZA888089B publication Critical patent/ZA888089B/xx

Links

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
- C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
- C07D491/04—Ortho-condensed systems
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
- C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
- C07D491/04—Ortho-condensed systems
- C07D491/044—Ortho-condensed systems with only one oxygen atom as ring hetero atom in the oxygen-containing ring
- C07D491/048—Ortho-condensed systems with only one oxygen atom as ring hetero atom in the oxygen-containing ring the oxygen-containing ring being five-membered
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A61P27/06—Antiglaucoma agents or miotics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/08—Vasodilators for multiple indications
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
- C07D495/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
- C07D495/04—Ortho-condensed systems

Landscapes

Organic Chemistry (AREA)
Chemical & Material Sciences (AREA)
Health & Medical Sciences (AREA)
Bioinformatics & Cheminformatics (AREA)
Engineering & Computer Science (AREA)
General Health & Medical Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Life Sciences & Earth Sciences (AREA)
Animal Behavior & Ethology (AREA)
Medicinal Chemistry (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Ophthalmology & Optometry (AREA)
Neurology (AREA)
Biomedical Technology (AREA)
Neurosurgery (AREA)
Heart & Thoracic Surgery (AREA)
Hospice & Palliative Care (AREA)
Psychiatry (AREA)
Cardiology (AREA)
Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Nitrogen Condensed Heterocyclic Rings (AREA)

ZA888089A 1987-10-29 1988-10-28 Tetrahydro-furo and-thieno/2,3-c/piridines ZA888089B (en)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
DE19873736664 DE3736664A1 (de)	1987-10-29	1987-10-29	Tetrahydro-furo- und -thieno(2,3-c)pyridine, ihre verwendung als arzneimittel und verfahren zu ihrer herstellung

Publications (1)

Publication Number	Publication Date
ZA888089B true ZA888089B (en)	1990-07-25

Family

ID=6339349

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
ZA888089A ZA888089B (en)	1987-10-29	1988-10-28	Tetrahydro-furo and-thieno/2,3-c/piridines

Country Status (17)

Country	Link
EP (1)	EP0314154A3 (cs)
JP (1)	JPH01157983A (cs)
KR (1)	KR890006650A (cs)
AU (1)	AU2443588A (cs)
CS (1)	CS273193B2 (cs)
DD (1)	DD283395A5 (cs)
DE (1)	DE3736664A1 (cs)
DK (1)	DK603588A (cs)
FI (1)	FI884947A7 (cs)
HU (1)	HU201553B (cs)
IL (1)	IL88184A0 (cs)
NO (1)	NO884835L (cs)
PL (1)	PL275555A1 (cs)
PT (1)	PT88899B (cs)
SU (1)	SU1657064A3 (cs)
YU (1)	YU201288A (cs)
ZA (1)	ZA888089B (cs)

Families Citing this family (37)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
FR2623810B2 (fr) *	1987-02-17	1992-01-24	Sanofi Sa	Sels de l'alpha-(tetrahydro-4,5,6,7 thieno(3,2-c) pyridyl-5) (chloro-2 phenyl) -acetate de methyle dextrogyre et compositions pharmaceutiques en contenant
US5272148A (en) *	1992-09-09	1993-12-21	Hoechst-Roussel Pharmaceuticals Incorporated	Heteroarenylpiperazines
US8914114B2 (en)	2000-05-23	2014-12-16	The Feinstein Institute For Medical Research	Inhibition of inflammatory cytokine production by cholinergic agonists and vagus nerve stimulation
ATE398624T1 (de) *	2000-07-06	2008-07-15	Daiichi Sankyo Co Ltd	Säure-additionssalze von hydropyridinderivaten
US20040048795A1 (en) *	2002-02-26	2004-03-11	North Shore-Long Island Jewish Research Institute	Inhibition of inflammatory cytokine production by stimulation of brain muscarinic receptors
US8729129B2 (en)	2004-03-25	2014-05-20	The Feinstein Institute For Medical Research	Neural tourniquet
US10912712B2 (en)	2004-03-25	2021-02-09	The Feinstein Institutes For Medical Research	Treatment of bleeding by non-invasive stimulation
US11207518B2 (en)	2004-12-27	2021-12-28	The Feinstein Institutes For Medical Research	Treating inflammatory disorders by stimulation of the cholinergic anti-inflammatory pathway
CN102793972A (zh)	2004-12-27	2012-11-28	范因斯坦医学研究院	通过电刺激迷走神经治疗炎症性疾病
TWI392681B (zh) *	2006-04-06	2013-04-11	Daiichi Sankyo Co Ltd	高純度普拉格雷及其酸加成鹽之製法
HRP20140668T1 (hr) *	2007-03-02	2014-10-10	Daiichi Sankyo Company, Limited	Postupak proizvodnje prasugrel hidroklorida visoke äśistoä†e
US8391970B2 (en)	2007-08-27	2013-03-05	The Feinstein Institute For Medical Research	Devices and methods for inhibiting granulocyte activation by neural stimulation
US9662490B2 (en)	2008-03-31	2017-05-30	The Feinstein Institute For Medical Research	Methods and systems for reducing inflammation by neuromodulation and administration of an anti-inflammatory drug
US9211409B2 (en)	2008-03-31	2015-12-15	The Feinstein Institute For Medical Research	Methods and systems for reducing inflammation by neuromodulation of T-cell activity
US8996116B2 (en)	2009-10-30	2015-03-31	Setpoint Medical Corporation	Modulation of the cholinergic anti-inflammatory pathway to treat pain or addiction
US9211410B2 (en)	2009-05-01	2015-12-15	Setpoint Medical Corporation	Extremely low duty-cycle activation of the cholinergic anti-inflammatory pathway to treat chronic inflammation
WO2010144578A2 (en)	2009-06-09	2010-12-16	Setpoint Medical Corporation	Nerve cuff with pocket for leadless stimulator
WO2014169145A1 (en)	2013-04-10	2014-10-16	Setpoint Medical Corporation	Closed-loop vagus nerve stimulation
US9833621B2 (en)	2011-09-23	2017-12-05	Setpoint Medical Corporation	Modulation of sirtuins by vagus nerve stimulation
CN105126248B (zh)	2009-12-23	2018-06-12	赛博恩特医疗器械公司	用于治疗慢性炎症的神经刺激设备和系统
US12172017B2 (en)	2011-05-09	2024-12-24	Setpoint Medical Corporation	Vagus nerve stimulation to treat neurodegenerative disorders
EP2707094B1 (en)	2011-05-09	2016-02-03	Setpoint Medical Corporation	Single-pulse activation of the cholinergic anti-inflammatory pathway to treat chronic inflammation
US9572983B2 (en)	2012-03-26	2017-02-21	Setpoint Medical Corporation	Devices and methods for modulation of bone erosion
US11311725B2 (en)	2014-10-24	2022-04-26	Setpoint Medical Corporation	Systems and methods for stimulating and/or monitoring loci in the brain to treat inflammation and to enhance vagus nerve stimulation
US11406833B2 (en)	2015-02-03	2022-08-09	Setpoint Medical Corporation	Apparatus and method for reminding, prompting, or alerting a patient with an implanted stimulator
US10596367B2 (en)	2016-01-13	2020-03-24	Setpoint Medical Corporation	Systems and methods for establishing a nerve block
CN108882885A (zh)	2016-01-20	2018-11-23	赛博恩特医疗器械公司	迷走神经刺激的控制
US10314501B2 (en)	2016-01-20	2019-06-11	Setpoint Medical Corporation	Implantable microstimulators and inductive charging systems
US11471681B2 (en)	2016-01-20	2022-10-18	Setpoint Medical Corporation	Batteryless implantable microstimulators
US10583304B2 (en)	2016-01-25	2020-03-10	Setpoint Medical Corporation	Implantable neurostimulator having power control and thermal regulation and methods of use
US11173307B2 (en)	2017-08-14	2021-11-16	Setpoint Medical Corporation	Vagus nerve stimulation pre-screening test
US11260229B2 (en)	2018-09-25	2022-03-01	The Feinstein Institutes For Medical Research	Methods and apparatuses for reducing bleeding via coordinated trigeminal and vagal nerve stimulation
US12343535B2 (en)	2019-04-12	2025-07-01	Setpoint Medical Corporation	Vagus nerve stimulation to treat neurodegenerative disorders
AU2021207815B2 (en)	2020-01-13	2026-03-26	The Feinstein Institutes For Medical Research	Treating bleeding and bleeding disorders via high intensity focused ultrasound stimulation of the spleen
US11938324B2 (en)	2020-05-21	2024-03-26	The Feinstein Institutes For Medical Research	Systems and methods for vagus nerve stimulation
WO2022245878A1 (en)	2021-05-17	2022-11-24	Setpoint Medical Corporation	Neurostimulation parameter authentication and expiration system for neurostimulation
US20250229086A1 (en)	2022-01-20	2025-07-17	Setpoint Medical Corporation	Treatment of inflammatory disorders

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
FR2315274A1 (fr) *	1975-06-27	1977-01-21	Parcor	Nouveaux derives de la thieno (2,3-c) pyridine, leur preparation et leurs applications
FR2317303A1 (fr) *	1975-07-09	1977-02-04	Parcor	Procede de preparation de derives de la tetrahydrothieno (3,2-c) et (2,3-c) pyridine

1987
- 1987-10-29 DE DE19873736664 patent/DE3736664A1/de not_active Withdrawn
1988
- 1988-10-27 IL IL88184A patent/IL88184A0/xx unknown
- 1988-10-27 CS CS712688A patent/CS273193B2/cs unknown
- 1988-10-27 FI FI884947A patent/FI884947A7/fi not_active IP Right Cessation
- 1988-10-27 DD DD88321141A patent/DD283395A5/de not_active IP Right Cessation
- 1988-10-27 YU YU02012/88A patent/YU201288A/xx unknown
- 1988-10-28 SU SU884356747A patent/SU1657064A3/ru active
- 1988-10-28 KR KR1019880014063A patent/KR890006650A/ko not_active Withdrawn
- 1988-10-28 HU HU885642A patent/HU201553B/hu not_active IP Right Cessation
- 1988-10-28 PL PL27555588A patent/PL275555A1/xx unknown
- 1988-10-28 DK DK603588A patent/DK603588A/da not_active Application Discontinuation
- 1988-10-28 AU AU24435/88A patent/AU2443588A/en not_active Abandoned
- 1988-10-28 JP JP63272853A patent/JPH01157983A/ja active Pending
- 1988-10-28 ZA ZA888089A patent/ZA888089B/xx unknown
- 1988-10-28 NO NO88884835A patent/NO884835L/no unknown
- 1988-10-28 PT PT88899A patent/PT88899B/pt not_active IP Right Cessation
- 1988-10-28 EP EP19880117961 patent/EP0314154A3/de not_active Withdrawn

Also Published As

Publication number	Publication date
FI884947L (fi)	1989-04-30
YU201288A (en)	1990-08-31
HU201553B (en)	1990-11-28
NO884835D0 (no)	1988-10-28
JPH01157983A (ja)	1989-06-21
NO884835L (no)	1989-05-02
DK603588D0 (da)	1988-10-28
FI884947A7 (fi)	1989-04-30
DK603588A (da)	1989-04-30
EP0314154A3 (de)	1990-12-05
AU2443588A (en)	1989-07-13
CS712688A2 (en)	1990-06-13
PT88899B (pt)	1993-01-29
CS273193B2 (en)	1991-03-12
DD283395A5 (de)	1990-10-10
SU1657064A3 (ru)	1991-06-15
FI884947A0 (fi)	1988-10-27
HUT50824A (en)	1990-03-28
PL275555A1 (en)	1989-05-02
KR890006650A (ko)	1989-06-15
EP0314154A2 (de)	1989-05-03
DE3736664A1 (de)	1989-05-11
IL88184A0 (en)	1989-06-30

Publication	Publication Date	Title
ZA888089B (en)	1990-07-25	Tetrahydro-furo and-thieno/2,3-c/piridines
GR3001763T3 (en)	1992-11-23	Cycloalkano(1,2-b)indole-sulfonamides
ZA884603B (en)	1989-03-29	2,5-dihydropyrroles
ZA889710B (en)	1989-12-27	4-aralkyl-5-substituted-1,2,4-triazole-5-thiols
KR970009590B1 (en)	1997-06-14	1.2.3.4.-tetrahydro -5-nitropyrimidine derivatives
EP0316843A3 (en)	1990-12-05	1,2,3,4-tetrahydro-5-nitropyrimidine derivatives
EP0217214B1 (en)	1990-05-02	2,4-dioxopyrrolo(2,3-c)pyrroles
IL83679A0 (en)	1988-01-31	2,4,6-trihydroxy-s-triazine derivatives
ZA889251B (en)	1989-08-30	8,9-annelated-beta-carbolines and 8,9-annelated-3,4-dihydro-beta-carbolines
GR3000539T3 (en)	1991-07-31	3,4-dihydro-2h-pyrans
JPS6450861A (en)	1989-02-27	3,5-dialkyl-1-arylpyrazoles
JPS6434951A (en)	1989-02-06	Vermicide based on 2,3-diaminomaleonitrile derivative
CS569987A1 (en)	1988-06-15	Zpusob vyroby 2 naftylamin 6,8 disulfonove kyseliny
CS22787A1 (en)	1988-06-15	Zpusob pripravy 2,6-dialkoxybenzonitrilu
ZA871249B (en)	1987-08-12	Cycloalkano(1,2-b)-indole-sulphonamides
IE871970L (en)	1988-03-08	2,7-methanobenzoxazonines
CS689087A1 (en)	1988-07-15	Zpusob vyroby 2,5 dichloranilin 4 sulfonove kyseliny
CS569887A1 (en)	1988-06-15	Zpusob izolace 2 naftol 6,8 disulfonove kyseliny
IE871771L (en)	1988-01-07	1,4-piperazines
IE872988L (en)	1988-05-06	2,6-diamino-3-halobenzylpyridines
CS770787A1 (en)	1988-06-15	Sposob pripravy 2,2 dibenzotiazolyldisulfidu
CS161787A1 (en)	1988-07-15	N oxidy 2,2,5 trimetyl 3 alkyloxazolidinov
GB8712993D0 (en)	1987-07-08	1,2-alkylidene-3-phosphoryl-glycerol derivatives
ZA884493B (en)	1989-03-29	2,2-dimethylchroman-3-o 1 derivatives
CS438087A1 (en)	1988-06-15	Zpusob pripravy 2 methyl 7,8 oktadecinu